Tomoko Kato Selected Research

Chimerin 1

3/2015

Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoko Kato Research Topics

Disease

7	Insulin Resistance 09/2021 - 01/2004
5	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 03/2015
5	Type 2 Diabetes Mellitus (MODY) 01/2016 - 12/2010
4	Heart Failure 06/2012 - 11/2005
3	Hyperglycemia 01/2015 - 12/2007
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013 - 12/2010
2	Obesity 09/2021 - 11/2019
2	Diabetes Mellitus 01/2016 - 02/2011
2	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 01/2015
2	Lung Neoplasms (Lung Cancer) 01/2015 - 12/2011
2	Tuberculosis (Tuberculoses) 02/2014 - 01/2005
2	Hypertrophy 08/2006 - 04/2006
2	Inflammation (Inflammations) 08/2006 - 04/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 03/2004 - 01/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 06/2021
1	Gonadal Dysgenesis (Gonadal Agenesis) 03/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Stupor 01/2017
1	Inappropriate ADH Syndrome (SIADH) 01/2017
1	Amyloid Plaque 01/2016
1	MELAS Syndrome (Syndrome, MELAS) 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Congenital Diaphragmatic Hernias 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Glucagonoma 01/2015
1	Adenocarcinoma 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Encephalomyelitis (Myeloencephalitis) 03/2014
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 03/2014
1	Extensively Drug-Resistant Tuberculosis 03/2014
1	Parasomnias (Parasomnia) 01/2013
1	Anterograde Amnesia 01/2013
1	Weight Gain 01/2012
1	Colonic Neoplasms (Colon Cancer) 12/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2011
1	Carcinogenesis 12/2011
1	Neoplasms (Cancer) 12/2011

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 01/2004
5	Insulin (Novolin)FDA Link 01/2015 - 12/2007
3	Triglycerides (Triacylglycerol)IBA 09/2021 - 04/2010
3	Amyloid (Amyloid Fibrils)IBA 01/2021 - 12/2015
3	Insulin Glargine (Lantus)FDA Link 01/2016 - 12/2010
2	Ferritins (Ferritin)IBA 01/2022 - 06/2021
2	Monoclonal AntibodiesIBA 06/2021 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2016
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2015 - 01/2012
2	AntibodiesIBA 03/2014 - 02/2011
2	LipidsIBA 06/2012 - 08/2006
2	SaltsIBA 08/2006 - 04/2006
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2006 - 11/2005
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	IronIBA 01/2022
1	PrionsIBA 04/2021
1	Peptides (Polypeptides)IBA 11/2019
1	Hormones (Hormone)IBA 11/2019
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 11/2019
1	IncretinsIBA 11/2019
1	(S-dinitrophenyl)-6-mercaptopurine riboside triphosphateIBA 03/2017
1	Carbon DioxideIBA 01/2017
1	Vasopressins (Vasopressin)IBA 01/2017
1	SodiumIBA 01/2017
1	erucylphosphocholineIBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	Growth Differentiation Factor 15IBA 01/2016
1	Liraglutide FDA Link 01/2016
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2016
1	(E,E)- 1- fluoro- 2,5- bis- (3- hydroxycarbonyl- 4- hydroxy)styrylbenzeneIBA 01/2016
1	fibroblast growth factor 21IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 03/2015
1	Chimerin 1IBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	mitiglinideIBA 01/2015
1	LigandsIBA 01/2015
1	Thyroglobulin FDA Link 01/2015
1	Sulfonylurea ReceptorsIBA 01/2015
1	AntigensIBA 03/2014
1	Pharmaceutical PreparationsIBA 03/2014
1	Hypnotics and Sedatives (Sedatives)IBA 01/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2013
1	DiglyceridesIBA 06/2012
1	Protein Kinase CIBA 06/2012
1	CeramidesIBA 06/2012
1	Adenosine Triphosphate (ATP)IBA 06/2012
1	Protein Isoforms (Isoforms)IBA 06/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2012
1	Prostaglandins EIBA 12/2011
1	ProstaglandinsIBA 12/2011
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2011
1	Indomethacin (Indometacin)FDA LinkGeneric 12/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2011
1	InterferonsIBA 02/2011

Therapy/Procedure

4	Therapeutics 01/2022 - 02/2011
3	Glycemic Control 01/2016 - 01/2012
1	Extracorporeal Membrane Oxygenation 01/2016
1	Membrane Oxygenators (Membrane Oxygenator) 01/2016
1	Heart-Assist Devices 06/2012